Private equity firms invested about USD 3.7 billion across 133 deals during the first quarter of 2018 as compared to USD 7.3 billion by way of 200 transactions a year ago.
'I can say with confidence that any future SARS-CoV-2 vaccine, developed anywhere in the world, would have to be manufactured in India, if it is to be affordable and of high quality.'
Major drug discovery outsourcing deals have almost dried up in the past 18 months for almost all prominent players in the area
The company said it will appoint a new Chairman at the next Board meeting.
Professor Shankar Balasubramanian has been awarded the prize, worth 10,000 pounds, for his work on Solexa sequencing, the high speed genome sequencing technology that means it is now possible to sequence a human genome for less than $10,000.
Garima Bharucha, 39, from Mumbai shares her inspiring fitness journey and the lessons she learned along the way.
Plans to set up an integrated pharma firm in a phased manner.
Harvard-educated Piramal is also in the boards of several companies, including Piramal Life Sciences, SBI Capital Markets Ltd and Prudential ICICI Management.
Indian drug companies, which have introduced copies of biotechnology drugs in the country, are bullish over the marketing prospects of 'biogenerics' after patents expire in developed markets. Experts say Indian companies may not repeat the success they achieved in selling generic medicines in biogenerics. The cost of clinical trials and the absence of substitutability will ensure that only those with deep pockets to launch such products globally will succeed, they feel.
"I believe that we have the potential of dominating the Asian economy," he said.
PLSL's lead molecule under development for cancer treatment has completed two Phase-I studies.
The Department of Management Sciences, University of Pune's two year full time MBA (Biotechnology) Degree programme.
Companies are back with their hiring plans as the economy shows signs of recovery with a boost in domestic demand.
Indian venture capitalists and private equities are expected to invest over $8.5 billion (about Rs 42,000 crore) in the next five years in sectors like biotechnology, life sciences, film production and education, an Assocham-Deloitte study said.
Applications are invited for PG Diploma Course in Stem Cell Technology & Tissue Engineering (Full Time.
According to the decision, such entities can now first operate through e-commerce and then open brick-and-mortar stores.
Investment by PEs into HLS sector dropped to $203 million in 2008-09 from $836 million in 2007-08, while the number of deals dropped 51 per cent to 21 from 43 deals. Similarly, VC investments also declined to $48 million from $80 million. In terms of deals, they dropped to 11 from 14.
Council of Scientific and Industrial Research offeres grants for young researchers in a variety of science and math fields. Funds up to three years of research.
Infosys Technologies is looking for acquistion of companies within $50 and $100-million revenue range in the segment of banking and financial services, besides health and life sciences, Infosys COO Kris Gopalakrishnan said.
While 2017 was a record year for private equity investments in India after $23.5 billion in 660 deals, 2018 too has begun with a bang.
The study finds that copper-coated surfaces can significantly reduce the concentration of the influenza-A virus on them, raising hopes that it may also be effective against other strains of the virus.
Indian drug makers may lose out on outsourcing contracts as overseas pharmaceutical companies defer their visits to the country in the wake of Mumbai terror attacks, according to industry experts.
Manipal Institute of Regenerative Medicine (MIRM) of Manipal University has launched a short term course on Application of Flow Cytometry and Molecular Biology Techniques in Stem Cell Biology and Regenerative Medicine.
Central Institute of Medicinal and Aromatic Plants (CIMAP) opens admissions to its PhD programme.
Job portals like Monster.com and Naukri.com affirmed the observation.
University of Madras offers many programmes from the Department of Zoology. "How to Apply" details found inside.
National Institute of Virology, Pune, needs research assistants for an upcoming project. Walk-in interview on 12 July 2007.
While company executives refused to divulge further details, industry sources said that Reliance has earmarked a huge area in the SEZ for the project.
University of Mysore offers three degree programmes, including a Master's degree in Information Technology.
The Padma Shri winner and eminent scientist speaks to Senior Editor Ajit Jain
Pavin Rao, a 28-year company veteran, to be second-in-command at Infosys.
US giants are rushing to partner with Indian and Chinese companiestapping their brainpower and saving millions of dollars in the search for breakthrough treatments
India is one of the fastest growing FDI sources for the United States with investors from the country more interested in US' aerospace and textile sectors.
India has signed an agreement with the Canadian Light Source and the University of Saskatchewan to promote synchrotron research, a high tech area of nuclear research.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
India's leading drug maker Ranbaxy Laboratories is likely to announce a drug discovery research tie-up with US drug manufacturer Merck soon. Ranbaxy's ongoing research collaboration with GSK also relates to the pre-clinical trial phase of the new drug, with significant milestone payment and post-commercialisation royalty possibilities. Ranbaxy's decision to de-merge its research operations was intended at having more collaborative research programmes involving foreign firms.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Canada has offered its partnership in areas like agriculture, mining, life sciences, ICT, financial services and infrastructure. Canada's aim in India was to create new Canadian connections in sectors like agriculture, mining, life sciences, information and communication technology (ICT), financial services and infrastructure, areas where that country's firms have proven expertise. Canadian rep hoped to see Canadian companies becoming active in the Indian market & vice versa.
RPG Life Sciences said on Wednesday it will undergo a restructuring process, wherein its pharmaceutical business and investments will be transfered to two of its group companies.
Assam University, Silchar, invites applications for its various academic programmes for the 2006-07 session.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances